Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials-Reference-Cited by-同舟云学术

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

Published:2007-01 Issue:1 Volume:29 Page:139-153
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Buse John B.,Klonoff David C.,Nielsen Loretta L.,Guan Xuesong,Bowlus Christopher L.,Holcombe John H.,Maggs David G.,Wintle Matthew E.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Importance of weight management in type 2 diabetes: Review with metaanalysis of clinical studies;Anderson;J Am Coll Nutr,2003

2. Obesity and type 2 diabetes;Maggio;Endocrinol Metab Clin North Am,2003

3. The epidemic of obesity;Stein;J Clin Endocrinol Metab,2004

4. Diabetes trends in the U.S.: 1990–1998;Mokdad;Diabetes Care,2000

5. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001;Mokdad;JAMA,2003

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like Peptide-1 Receptor Agonists for Weight Loss in Orthopaedic Surgery: A Comprehensive Review;JBJS Journal of Orthopaedics for Physician Assistants;2024-07

2. Glucagon-Like Peptide Receptor-1 Agonists Used for Medically-Supervised Weight Loss in Patients With Hip and Knee Osteoarthritis: Critical Considerations for the Arthroplasty Surgeon;Arthroplasty Today;2024-06

3. GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment;Gastroenterology Insights;2024-02-18

4. Medical Weight Optimization for Arthroplasty Patients: A Primer of Emerging Therapies for the Joint Arthroplasty Surgeon;The Journal of Arthroplasty;2024-01

5. The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease;Diabetologia;2023-07-27